OXALIPLATIN (Pfizer Laboratories Div Pfizer Inc.)
Welcome to the PulseAid listing for the OXALIPLATIN drug offered from Pfizer Laboratories Div Pfizer Inc.. This Platinum-based Drug [EPC],Platinum-containing Compounds [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Pfizer Laboratories Div Pfizer Inc. |
NON-PROPRIETARY NAME: | OXALIPLATIN |
SUBSTANCE NAME: | OXALIPLATIN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Platinum-based Drug [EPC],Platinum-containing Compounds [Chemical/Ingredient] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | POWDER, FOR SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2012-08-09 |
END MARKETING DATE: | 0000-00-00 |
OXALIPLATIN HUMAN PRESCRIPTION DRUG Details:
Item Description | OXALIPLATIN from Pfizer Laboratories Div Pfizer Inc. |
LABELER NAME: | Pfizer Laboratories Div Pfizer Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 50(mg/10mL) |
START MARKETING DATE: | 2012-08-09 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0069-0067_2d79aad4-1444-4d81-a7e2-f98d303cbbce |
PRODUCT NDC: | 0069-0067 |
APPLICATION NUMBER: | ANDA200979 |
Other OXALIPLATIN Pharmaceutical Manufacturers / Labelers: